北京海一药业

Beijing Haiyi Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and manufacturing of high-end generic and innovative small molecule drugs. The company's therapeutic focus spans oncology, cardiovascular health, metabolic diseases, and the central nervous system. Beijing Haiyi operates an integrated platform that includes R&D centers and GMP-certified production facilities located in Beijing. Their portfolio includes a mix of marketed generic products and a pipeline of novel drug candidates currently in various stages of clinical development. The company aims to address unmet medical needs by providing high-quality pharmaceutical products to the domestic and international markets.